In the last trading session, 2.56 million shares of the Caribou Biosciences Inc (NASDAQ:CRBU) were traded, and its beta was 2.48. Most recently the company’s share price was $1.6, and it changed around $0.21 or 15.11% from the last close, which brings the market valuation of the company to $148.81M. CRBU currently trades at a discount to its 52-week high of $3.00, offering almost -87.5% off that amount. The share price’s 52-week low was $0.66, which indicates that the current value has risen by an impressive 58.75% since then. We note from Caribou Biosciences Inc’s average daily trading volume that its 10-day average is 2.38 million shares, with the 3-month average coming to 1.31 million.
Caribou Biosciences Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.29. If we narrow it down even further, the data shows that 0 out of 8 analysts rate the stock as a Sell; another 2 rate it as Overweight. Among the rest, 1 recommended CRBU as a Hold, whereas 5 deemed it a Buy, and 0 rated it as Underweight.
Caribou Biosciences Inc (NASDAQ:CRBU) trade information
Instantly CRBU has showed a green trend with a performance of 15.11% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 1.6400 on recent trading dayincreased the stock’s daily price by 2.44%. On the other hand, Caribou Biosciences Inc (NASDAQ:CRBU) is 46.79% up in the 30-day period. We can see from the shorts that 10.95 million shares have been sold at a short interest cover period of 9.39 day(s).
The consensus price target as assigned by Wall Street analysts is $3, which translates to bulls needing to increase their stock price by 46.67% from its current value. Analyst projections state that CRBU is forecast to be at a low of $3 and a high of $3.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -33.41%. Caribou Biosciences Inc earnings are expected to increase by 9.52% in 2025, but the outlook is positive 4.16% per year for the next five years.
CRBU Dividends
Caribou Biosciences Inc’s next quarterly earnings report is expected to be released on 2025-May-08.
Caribou Biosciences Inc (NASDAQ:CRBU)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 9.83% of Caribou Biosciences Inc shares, and 53.30% of them are in the hands of institutional investors. The stock currently has a share float of 59.11%. Caribou Biosciences Inc stock is held by 169.0 institutions, with BLACKROCK INC. being the largest institutional investor. By 2024-06-30, it held 7.6907% of the shares, which is about 6.95 million shares worth $11.39 million.
VANGUARD GROUP INC, with 5.0306% or 4.54 million shares worth $7.45 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF were the top two Mutual Funds as of Mar 31, 2025 . The former held 2.7 shares worth $4.32 million, making up 2.91% of all outstanding shares. On the other hand, iShares Trust-iShares Russell 2000 ETF held roughly 2.1 shares worth around $3.36 million, which represents about 2.26% of the total shares outstanding.
